Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionPnc Financial Services Group, Inc.
Latest Disclosed Ownership8,310 shares
Latest Disclosed Value $ 29,749
Pnc Financial Services Group, Inc. reports 16.31% increase in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 8, 2026 - Pnc Financial Services Group, Inc. filed a 13F-HR form disclosing ownership of 8,310 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $23,393 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 7,145 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 16.31% during the quarter. The current value of the position is $20,276 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 8,310 1,165 16.31 30 16.00 0.0000
2026-02-06 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 7,145 637 9.79 25 19.05 0.0000
2025-11-07 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 6,508 -4,259 -39.56 21 -19.23 0.0000
2025-08-08 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 10,767 -9,897 -47.89 26 -81.02 0.0000
2025-05-09 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 20,664 -1,791 -7.98 138 -51.42 0.0001
2025-02-07 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 22,455 6,342 39.36 282 -5.05 0.0002
2024-11-08 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 16,113 577 3.71 298 -11.08 0.0002
2024-08-09 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 15,536 768 5.20 334 -15.87 0.0002
2024-05-10 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 14,768 -583 -3.80 398 -13.70 0.0003
2024-03-22 2023-12-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 15,351 -1,495 -8.87 460 33.33 0.0004
2024-02-09 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 15,351 -1,495 460 0.0001
2023-11-13 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 16,846 2,014 13.58 345 17.35 0.0003
2023-08-11 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 14,832 480 3.34 295 20.00 0.0003
2023-05-15 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 14,352 89 0.62 246 -12.19 0.0002
2023-02-10 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 14,263 1,955 15.88 279 42.35 0.0003
2022-11-10 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 12,308 657 5.64 196 21.74 0.0002
2022-08-12 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 11,651 3,390 41.04 161 22.90 0.0002
2022-05-12 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 8,261 -29 -0.35 131 -28.02 0.0001
2022-02-11 2021-12-31 13F ROCKET Common Stock 77313F106 8,290 -347 -4.02 182 -29.73 0.0002
2021-11-05 2021-09-30 13F ROCKET Common Stock 77313F106 8,637 340 4.10 259 -29.62 0.0002
2021-08-06 2021-06-30 13F ROCKET Common Stock 77313F106 8,297 651 8.51 368 8.88 0.0003
2021-05-07 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 7,646 -905 -10.58 338 -27.78 0.0003
2021-02-12 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 8,551 -429 -4.78 468 127.18 0.0005
2020-11-06 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 8,980 0 0.00 206 9.57 0.0003
2020-08-28 2020-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 8,980 -620 -6.46 188 40.30 0.0003
2020-08-07 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 8,980 -620 188 39.0360
2020-05-08 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 9,600 9,600 134 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.